Generic Business Strategies > Unique Generic Products

In selecting generic product candidates to pursue, Barr seeks product candidates that may include one or more of the following characteristics:

• PRODUCT BARRIERS

- Difficult to Formulate or Manufacture

• PATENT BARRIERS

- Formulation, Raw Material, Molecule

• MARKETING BARRIERS

- Risk Management Programs, Pregnancy Registry

Generic products with some or all of these characteristics typically face limited competition and may produce higher returns for a longer period of time than products without these characteristics. A good example of this strategy is Barr’s generic oral contraceptive franchise, where revenues have increased from $93 million in fiscal 2002 to $399 million in fiscal 2006.

Generic Business Overview
Generic Business Strategies
•Unique Generic Products
•Patent Challenges
•New Technology Platforms
•Corporate Development
Key Generic Products
Generic Product Pipeline
Generic Sales Process
FAQ About Generics
FDA Approval Process
History of Generic Industry
Industry Links
Clinical Trials